Infection risk study for adults with Crohn's or colitis
Part of Digestive system clinical trials.
This study looks at patients with ulcerative colitis or Crohn's disease who are on Medicare and taking medication for their condition. It will check how often infections happen and aims to understand infection risks better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least one prescription for a UC or Crohn's medication.
- You have had two or more medical visits for UC or Crohn's at least 30 days apart.
- You are enrolled in Medicare (Part A/B or Medicare Advantage).
- You have not taken any of those medications in the 12 months before the study starts.
- You do not have certain other conditions like rheumatoid arthritis, psoriasis, or a recent non-skin cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a treat-to-target approach works for people with Crohn's disease or ulcerative colitis in everyday medical care. By reviewing your medical history over the past 2 years, researchers hope to learn how to better manage these conditions and prevent long-term damage.
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
This study tests advanced treatments for people with moderate to severe Crohn's disease or ulcerative colitis who haven't responded to at least one previous therapy. It aims to find better options for managing these conditions.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study follows adults with Crohn's disease, ulcerative colitis, or unclassified IBD to better understand the links between these conditions, cancer, and serious infections. It asks you to share personal details and complete online surveys over time.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.